[
  {
    "objectID": "software/index.html",
    "href": "software/index.html",
    "title": "Software",
    "section": "",
    "text": "This page contains software I have developed over the years. I will be uploading sporadically but my aim is to publish all code used in papers I’ve first authored or co-authored."
  },
  {
    "objectID": "software/index.html#overview",
    "href": "software/index.html#overview",
    "title": "Software",
    "section": "",
    "text": "This page contains software I have developed over the years. I will be uploading sporadically but my aim is to publish all code used in papers I’ve first authored or co-authored."
  },
  {
    "objectID": "software/index.html#this-website",
    "href": "software/index.html#this-website",
    "title": "Software",
    "section": "This Website",
    "text": "This Website\n\nThis is a Quarto Website .\nQuarto websites are a type of RStudio Project.\nBuilt and is maintained in RStudio and Positron.\nEach webpage is edited as a Quarto document.\nA YAML file is used to organize the Quarto document webpages into a functional website.\nThe updated files are committed to my local Git Repository used for version control.\nThe committed changes are pushed to the remote GitHub Repository which uploading any new files simultaneously\nThe remote repository GitHub files are then processed with GitHub Actions - automatically triggered by the git push - which builds and deploys the Quarto website to GitHub Pages, forming this website: https://candrewbasham.github.io/web/."
  },
  {
    "objectID": "software/index.html#phd-thesis-research",
    "href": "software/index.html#phd-thesis-research",
    "title": "Software",
    "section": "PhD Thesis Research",
    "text": "PhD Thesis Research\n\nPost-TB Airway Disease\n\nR code\nSurvival analysis (Rmd) with hdPS, lasso-hdPS, robust Poisson, and other sensitivity analyses.\n\n\nJournal Article\n\nhttps://doi.org/10.1016/j.eclinm.2021.100752\n\n\n\nTB-Associated Depression\n\nR code\nMediation analysis of depression risk by TB via hospital LOS (ordinal measure)\n\n\nJournal Article\n\nhttps://www.sciencedirect.com/science/article/abs/pii/S1047279721001253?via%3Dihub\n\n\n\nMultimorbidity Prevalence and Chronic Disease Patterns\n\nR code\nMultimorbidity prevalence ratios comparing TB survivors with non-TB controls\n\n\nJournal Article\n\nhttps://doi.org/10.17269/s41997-022-00711-y"
  },
  {
    "objectID": "sci_med_writing/index.html",
    "href": "sci_med_writing/index.html",
    "title": "Writing and Reviewing",
    "section": "",
    "text": "This page is a collection of guidance documents for writing and reviewing quantitative bioscience research articles.\n\n\n\n\nBasic Statistical Reporting for Articles Published in Biomedical Journals: The “Statistical Analyses and Methods in the Published Literature” or The SAMPLGuidelines\n\n\n\n\n\n\n\n\n\n\nLang and Altman (2013) SAMPL\n\n\n\n\nFigure 1"
  },
  {
    "objectID": "sci_med_writing/index.html#overview",
    "href": "sci_med_writing/index.html#overview",
    "title": "Writing and Reviewing",
    "section": "",
    "text": "This page is a collection of guidance documents for writing and reviewing quantitative bioscience research articles.\n\n\n\n\nBasic Statistical Reporting for Articles Published in Biomedical Journals: The “Statistical Analyses and Methods in the Published Literature” or The SAMPLGuidelines\n\n\n\n\n\n\n\n\n\n\nLang and Altman (2013) SAMPL\n\n\n\n\nFigure 1"
  },
  {
    "objectID": "sci_med_writing/index.html#biomed-central-bmc-standards-of-reporting",
    "href": "sci_med_writing/index.html#biomed-central-bmc-standards-of-reporting",
    "title": "Writing and Reviewing",
    "section": "BioMed Central (BMC) Standards of Reporting",
    "text": "BioMed Central (BMC) Standards of Reporting\nThis list was derived from BMC’s Standards of Reporting, which I shortened to the tools’ name with URL link and the type of study they are designed for:\n\n\nRandomized controlled trials (CONSORT)\nProtocols for randomized controlled protocols (SPIRIT)\nSystematic reviews and meta-analyses* (PRISMA) and protocols (PRISMA-P)\nObservational studies (STROBE)\nCase reports (CARE)\nQualitative research (COREQ)\nDiagnostic/prognostic studies (STARDand TRIPOD)\nEconomic evaluations (CHEERS)\nPre-clinical animal studies (ARRIVE)\nStatistics checklists for editors and reviewers to use when evaluating the statistics in manuscripts:\n\nLife Sciences journals\nMedical journals\nStatistics, Mathematics and Computer Science journals\n\nsystematic reviews Cochrane Reviewers’ Handbook.\n\n\nhttps://www.biomedcentral.com/p/the-bmc-series-journals/for-reviewers#reviewing+a+bmc+series+manuscript"
  },
  {
    "objectID": "projects/index.html",
    "href": "projects/index.html",
    "title": "Projects",
    "section": "",
    "text": "The goal of this program of research is to advance theory, concepts, models, and tools for descriptive, predictive, and inferences about critical illness survivor health outcomes, their pathology and diagnosis, biomedical treatment, the physiological and psychological changes associated with these processes, and their sociocultural contexts, including financial and economic burdens, healthcare services, and advances in pharmaceutical treatment , aprocesses, services relevant to them.\nI am creating an international network of epidemiologists studying critical illness survivorship. The object of this network is the establishment of an academic society dedicated to advancing dialogue, theory, methods, and applications to improve the rigor, representativeness, relevance, and reproducibility of the epidemiological study of critical illness survivorship.\n\n\n\nDistilling epidemiological principles common to survivorship and forming them into coherent quantitative theory,\nDeveloping epidemiological methods to analyze survivor health outcomes selecting relevant com- parator groups, and coupling them with estimators that can reasonably be assumed to estimate quantities of interest in survivorship research;\nDefine the limits of generalizability for estimands and estimators within and across fields of medicine, patient populations, and geographies.\n\n\n\n\n\nBasham CA, Romanowski K, Johnston JC. Life after tuberculosis: planning for health. Lancet Respiratory Medicine. 2019;7(12):1004–1006.\nBasham CA. Post–tuberculosis outcomes science: a sub–discipline for TB survivorship research? International Journal of Tuberculosis and Lung Disease. 2021; 25(6):498-501.\nBasham CA, Smith S, Romanowski K, Johnston JC. Cardiovascular morbidity and mortality among people diagnosed with tuberculosis: a systematic review and meta-analysis. PLoS ONE 15(7):e0235821.\nBasham CA, Cook, VJ, Johnston JC. Towards a ‘fourth 90’: A population–based analysis of post–tuberculosis pulmonary function testing in British Columbia, Canada, 1985–2015. European Respiratory Journal. April 2020:2000384.\nBasham CA, Karim ME, Cook VJ, Patrick DM, Johnston JC. Post–tuberculosis mortality risk among immigrants to British Columbia, Canada, 1985–2015: a time–dependent Cox regression analysis of linked immigration, public health, and vital statistics data. Can J Public Heal. 2021;112(1):132–141.\nBasham CA, Karim ME, Cook, VJ, Patrick DM, Johnston JC. Post–tuberculosis airway disease among people immigrating to British Columbia, Canada, 1985–2015: a population–based cohort study. EClinicalMedicine. 2021;33:100752.\nBasham CA, Karim ME, Cook, VJ, Patrick DM, Johnston JC. Tuberculosis–associated depression risk: a population–based cohort study of people immigrating to British Columbia, Canada, 1985–2015. Annals of Epidemiology. 2021; 63: 7-14.\nBasham CA, Karim ME. An E–value analysis of potential unmeasured or residual confounding in systematic reviews of post–TB mortality, respiratory disease, and cardiovascular disease. Annals of Epidemiology. 2022; 68: 24-31.\nBasham CA, Karim ME, Johnston JC. Multimorbidity prevalence and chronic disease patterns among tuberculosis survivors in a high-income setting. Can J Public Heal. 2023 Apr;114(2):264-276."
  },
  {
    "objectID": "projects/index.html#survivorship-epidemiology",
    "href": "projects/index.html#survivorship-epidemiology",
    "title": "Projects",
    "section": "",
    "text": "The goal of this program of research is to advance theory, concepts, models, and tools for descriptive, predictive, and inferences about critical illness survivor health outcomes, their pathology and diagnosis, biomedical treatment, the physiological and psychological changes associated with these processes, and their sociocultural contexts, including financial and economic burdens, healthcare services, and advances in pharmaceutical treatment , aprocesses, services relevant to them.\nI am creating an international network of epidemiologists studying critical illness survivorship. The object of this network is the establishment of an academic society dedicated to advancing dialogue, theory, methods, and applications to improve the rigor, representativeness, relevance, and reproducibility of the epidemiological study of critical illness survivorship.\n\n\n\nDistilling epidemiological principles common to survivorship and forming them into coherent quantitative theory,\nDeveloping epidemiological methods to analyze survivor health outcomes selecting relevant com- parator groups, and coupling them with estimators that can reasonably be assumed to estimate quantities of interest in survivorship research;\nDefine the limits of generalizability for estimands and estimators within and across fields of medicine, patient populations, and geographies.\n\n\n\n\n\nBasham CA, Romanowski K, Johnston JC. Life after tuberculosis: planning for health. Lancet Respiratory Medicine. 2019;7(12):1004–1006.\nBasham CA. Post–tuberculosis outcomes science: a sub–discipline for TB survivorship research? International Journal of Tuberculosis and Lung Disease. 2021; 25(6):498-501.\nBasham CA, Smith S, Romanowski K, Johnston JC. Cardiovascular morbidity and mortality among people diagnosed with tuberculosis: a systematic review and meta-analysis. PLoS ONE 15(7):e0235821.\nBasham CA, Cook, VJ, Johnston JC. Towards a ‘fourth 90’: A population–based analysis of post–tuberculosis pulmonary function testing in British Columbia, Canada, 1985–2015. European Respiratory Journal. April 2020:2000384.\nBasham CA, Karim ME, Cook VJ, Patrick DM, Johnston JC. Post–tuberculosis mortality risk among immigrants to British Columbia, Canada, 1985–2015: a time–dependent Cox regression analysis of linked immigration, public health, and vital statistics data. Can J Public Heal. 2021;112(1):132–141.\nBasham CA, Karim ME, Cook, VJ, Patrick DM, Johnston JC. Post–tuberculosis airway disease among people immigrating to British Columbia, Canada, 1985–2015: a population–based cohort study. EClinicalMedicine. 2021;33:100752.\nBasham CA, Karim ME, Cook, VJ, Patrick DM, Johnston JC. Tuberculosis–associated depression risk: a population–based cohort study of people immigrating to British Columbia, Canada, 1985–2015. Annals of Epidemiology. 2021; 63: 7-14.\nBasham CA, Karim ME. An E–value analysis of potential unmeasured or residual confounding in systematic reviews of post–TB mortality, respiratory disease, and cardiovascular disease. Annals of Epidemiology. 2022; 68: 24-31.\nBasham CA, Karim ME, Johnston JC. Multimorbidity prevalence and chronic disease patterns among tuberculosis survivors in a high-income setting. Can J Public Heal. 2023 Apr;114(2):264-276."
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Welcome",
    "section": "",
    "text": "Welcome\n\n\n\n\n\n\nFigure 1: Dr. C Andrew Basham, B.A., M.Sc., Ph.D.\n\n\n\nThank you for visiting my open-source Quarto website.\n\n\nI am an epidemiologist specializing in causal inference using large relational healthcare databases. I have over 15 years experience using SAS and R working in professional collaborative coding environments producing decision-grade evidence with open science principles. As an educator, I provide world-class training that students require to prevail in highly competitive job markets.\nSincerely,\nC. Andrew Basham, PhD\nEmail: info\\@\\andrewbasham.com\nWeb: https://andrewbasham.com/\nLinkedIn: https://www.linkedin.com/in/candrewbasham/\nOpen Science Framework: https://osf.io/mny8b/\nGitHub: https://github.com/CAndrewBasham\nBluesky: https://bsky.app/profile/andrewbasham.bsky.social"
  },
  {
    "objectID": "CV/index.html",
    "href": "CV/index.html",
    "title": "CV",
    "section": "",
    "text": "Date Prepared:\nNovember \\(8^{th}\\), 2024\n\n\nName:\nChristopher Andrew Basham\n\n\nOffice:\n1620 Tremont Street - Unit 3030\nBoston, MA 02120\n\n\nEmail:\ncv@andrewbasham.com\n\n\nWebsite:\nhttps://andrewbasham.com/\n\n\nLinkedIn:\nhttps://www.linkedin.com/in/candrewbasham/\n\n\nORCiD:\nhttps://orcid.org/0000-0003-0506-7936\n\n\nGitHub Profile:\nhttps://github.com/CAndrewBasham\n\n\nGitHub Pages:\nhttps://candrewbasham.github.io/web/\n\n\nResearchGate:\nhttps://www.researchgate.net/profile/C-Andrew-Basham\n\n\nGoogle Scholar:\nhttps://tinyurl.com/3wz4sken\n\n\nOpen Science Framework:\nhttps://osf.io/mny8b/\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n09/2017-10/2021\nPhD\nPopulation and Public Health\nUniversity of British Columbia\n\n\n09/2010-02/2016\nMSc\nCommunity Health Sciences\nUniversity of Manitoba\n\n\n09/2004-05/2008\nBA\nEnvironmental/Urban Studies\nUniversity of Winnipeg\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n03/2022-06/2024\nResearch Fellow\nDivision of Pharmacoepidemiology and Pharmacoeconomics\nHarvard Medical School\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n03/2022– 06/2024\nResearch Fellow\nDivision of Pharmacoepidemiology and Pharmacoeconomics\nBrigham and Women’s Hospital\n\n\n\nOther Professional Positions:\n\n\n\n\n\n\n\nYear(s)\nPosition| Department| Institution|\n\n\n2008-2010\nHealth Policy Analyst | Health Department | Manitoba Keewatinowi Okimakanak | ——————————+—————————————————+———————————————|2012| Research Assistant| Department of Emergency Medicine| University of Manitoba| Statistical Analyst | First Nations Regional Longitudinal Health Survey | Assembly of Manitoba Chiefs | ——————————+—————————————————+———————————————| 2013 | Program Specialist | Aboriginal Health Programs | Winnipeg Regional Health Authority | | | |\n\n\n\n\n\n\n4-2015 | Research Assistant | Centre for Aboriginal Health Research | University of Manitoba | | | |\n\n\n\n5 | Research Consultant | Health Department | Manitoba Keewatinowi Okimakanak | | | |\n\n\n\n5-2017 | Data Analyst | Manitoba Centre for Health Policy | University of Manitoba | | | |\n\n\n\n7-2021 | Graduate Research Assistant | Tuberculosis Program | British Columbia Centre for Disease Control | | | |\n\n\n\n8 | Teaching Assistant | School of Population and Public Health | University of British Columbia | | | |\n\n\n\n9 | Graduate Research Assistant | Department of Pathology and Laboratory Medicine | University of British Columbia | | | |\n\n\n\n0-2021 | Graduate Research Assistant | Canadian Disability Participation Project | University of British Columbia | | | |\n\n\n\n1-2022 | Evidence Reviewer | McGill International TB Centre | McGill University | | | |\n\n\n\n2- | Statistical Consultant | Faculty of Health Sciences | Simon Fraser University | | | |"
  },
  {
    "objectID": "CV/index.html#contact-information",
    "href": "CV/index.html#contact-information",
    "title": "CV",
    "section": "",
    "text": "Date Prepared:\nNovember \\(8^{th}\\), 2024\n\n\nName:\nChristopher Andrew Basham\n\n\nOffice:\n1620 Tremont Street - Unit 3030\nBoston, MA 02120\n\n\nEmail:\ncv@andrewbasham.com\n\n\nWebsite:\nhttps://andrewbasham.com/\n\n\nLinkedIn:\nhttps://www.linkedin.com/in/candrewbasham/\n\n\nORCiD:\nhttps://orcid.org/0000-0003-0506-7936\n\n\nGitHub Profile:\nhttps://github.com/CAndrewBasham\n\n\nGitHub Pages:\nhttps://candrewbasham.github.io/web/\n\n\nResearchGate:\nhttps://www.researchgate.net/profile/C-Andrew-Basham\n\n\nGoogle Scholar:\nhttps://tinyurl.com/3wz4sken\n\n\nOpen Science Framework:\nhttps://osf.io/mny8b/"
  },
  {
    "objectID": "CV/index.html#education",
    "href": "CV/index.html#education",
    "title": "CV",
    "section": "",
    "text": "09/2017-10/2021\nPhD\nPopulation and Public Health\nUniversity of British Columbia\n\n\n09/2010-02/2016\nMSc\nCommunity Health Sciences\nUniversity of Manitoba\n\n\n09/2004-05/2008\nBA\nEnvironmental/Urban Studies\nUniversity of Winnipeg"
  },
  {
    "objectID": "CV/index.html#postdoctoral-training",
    "href": "CV/index.html#postdoctoral-training",
    "title": "CV",
    "section": "",
    "text": "03/2022-06/2024\nResearch Fellow\nDivision of Pharmacoepidemiology and Pharmacoeconomics\nHarvard Medical School"
  },
  {
    "objectID": "CV/index.html#appointments-at-hospitalsaffiliated-institutions",
    "href": "CV/index.html#appointments-at-hospitalsaffiliated-institutions",
    "title": "CV",
    "section": "",
    "text": "03/2022– 06/2024\nResearch Fellow\nDivision of Pharmacoepidemiology and Pharmacoeconomics\nBrigham and Women’s Hospital\n\n\n\nOther Professional Positions:\n\n\n\n\n\n\n\nYear(s)\nPosition| Department| Institution|\n\n\n2008-2010\nHealth Policy Analyst | Health Department | Manitoba Keewatinowi Okimakanak | ——————————+—————————————————+———————————————|2012| Research Assistant| Department of Emergency Medicine| University of Manitoba| Statistical Analyst | First Nations Regional Longitudinal Health Survey | Assembly of Manitoba Chiefs | ——————————+—————————————————+———————————————| 2013 | Program Specialist | Aboriginal Health Programs | Winnipeg Regional Health Authority | | | |\n\n\n\n\n\n\n4-2015 | Research Assistant | Centre for Aboriginal Health Research | University of Manitoba | | | |\n\n\n\n5 | Research Consultant | Health Department | Manitoba Keewatinowi Okimakanak | | | |\n\n\n\n5-2017 | Data Analyst | Manitoba Centre for Health Policy | University of Manitoba | | | |\n\n\n\n7-2021 | Graduate Research Assistant | Tuberculosis Program | British Columbia Centre for Disease Control | | | |\n\n\n\n8 | Teaching Assistant | School of Population and Public Health | University of British Columbia | | | |\n\n\n\n9 | Graduate Research Assistant | Department of Pathology and Laboratory Medicine | University of British Columbia | | | |\n\n\n\n0-2021 | Graduate Research Assistant | Canadian Disability Participation Project | University of British Columbia | | | |\n\n\n\n1-2022 | Evidence Reviewer | McGill International TB Centre | McGill University | | | |\n\n\n\n2- | Statistical Consultant | Faculty of Health Sciences | Simon Fraser University | | | |"
  },
  {
    "objectID": "Education/index.html#doctor-of-philosophy-2017-2021",
    "href": "Education/index.html#doctor-of-philosophy-2017-2021",
    "title": "Education",
    "section": "Doctor of Philosophy (2017-2021)",
    "text": "Doctor of Philosophy (2017-2021)\n\nUniversity of British Columbia, School of Population and Public Health\n\nDiploma\n\n\n\n[]\n\n\nFigure 1\n\n\n\n\n\nThesis\n\n\n\n\n\n\n\n\n\n\nFigure 2"
  },
  {
    "objectID": "Education/index.html#master-of-science-2010-2016",
    "href": "Education/index.html#master-of-science-2010-2016",
    "title": "Education",
    "section": "Master of Science (2010-2016)",
    "text": "Master of Science (2010-2016)\n\nUniversity of Manitoba, Department of Community Health Sciences\n\nDiploma\n\n\n\n\n\nThesis\n\n\n\n\nSource: University of Manitoba; &lt;https://mspace.lib.umanitoba.ca/server/api/core/bitstreams/c5bc5dab-9622-451d-92e4-1e289ba70998/content&gt; Accessed: Nov 2, 2024)."
  },
  {
    "objectID": "Education/index.html#bachelor-of-arts-2004-2008",
    "href": "Education/index.html#bachelor-of-arts-2004-2008",
    "title": "Education",
    "section": "Bachelor of Arts (2004-2008)",
    "text": "Bachelor of Arts (2004-2008)\n\nUniversity of Winnipeg, Environmental/Urban Studies, Issues in Sustainability (GPA: 4.01/4.50)\n\nDiploma"
  },
  {
    "objectID": "portfolio/index.html",
    "href": "portfolio/index.html",
    "title": "Portfolio",
    "section": "",
    "text": "Below are short descriptions of my professional work with links to research articles, policy documents, and media coverage."
  },
  {
    "objectID": "portfolio/index.html#tuberculosis-program-performance-measurement",
    "href": "portfolio/index.html#tuberculosis-program-performance-measurement",
    "title": "Portfolio",
    "section": "Tuberculosis Program Performance Measurement",
    "text": "Tuberculosis Program Performance Measurement\nMy first research interest was in TB epidemiology and program performance measurement through an equity lens. This interest was borne from my work with the Manitoba Keewatinowi Okimakanak ( for “Northern Manitoba Chiefs”), as a Health Policy Analyst My MSc thesis was based on working on the MKO TB Strategy, which included a project called “Finding Our Ancestors” and a call for the US-CDC Program Objectives and Performance Targets to be applied to the TB programming provided to MKO First Nations to ensure transparent review aimed at eliminating TB with community partnership established based on that common goal.\n\n\n\n\n\n\nFigure 1"
  },
  {
    "objectID": "portfolio/index.html#tuberculosis-survivor-health",
    "href": "portfolio/index.html#tuberculosis-survivor-health",
    "title": "Portfolio",
    "section": "Tuberculosis Survivor Health",
    "text": "Tuberculosis Survivor Health\nMy PhD thesis Tuberculosis Survivor Health investigated long-term health outcomes of people diagnosed with TB compared with non-TB controls using causal inference epidemiological methods."
  },
  {
    "objectID": "portfolio/index.html#tuberculosis-and-mental-health",
    "href": "portfolio/index.html#tuberculosis-and-mental-health",
    "title": "Portfolio",
    "section": "Tuberculosis and Mental Health",
    "text": "Tuberculosis and Mental Health\nI focused on TB and mental health as a key component of my PhD thesis research on TB survivor health. In addition to my research I served as an Executive Member on the International Union Against TB and Lung Disease TB-Mental Health Working Group.\n\nWorld TB Day Webinar on TB-Mental Health Integration\nI was a co-organizer of a World TB Day 2021 Webinar Integrating TB and Mental Health Services to End the Epidemic and presented an overview of systematic reviews on TB and mental health - focused on depression.\n\n\nThis presentation led to a 1:1 knowledge exchange with Dr Paula Fujiwara, which informed the structure and content of the USAID discussion document she was authoring on this topic.\n\n\nUSAID Evidence on TB and Mental Health\n\n\n\n\n\n\nFigure 2\n\n\n\n\n\nTB and the risk of depression\nCan TB lead to a higher risk of depression? Does the lenght of stay in hospital following TB diagnosis mediate the risk of depression caused by TB? To answer these research questions, I planned and conducted a causal mediation analysis of depression risk following tuberculosis diagnosis. In that analysis, the potential mediating role of the length of stay in hospital following TB diagnosis was evaluated. Results were presented at two conferences and then published in an academic journal.\n\nSymposium Speaker - World Conference on Lung Health 2021\n\n\n\n\n\n\nFigure 3\n\n\n\n\n\nOral Abstract - International Union Against TB and Lung Disease, North America Region 2021\n\n\n\n\n\n\nFigure 4\n\n\n\n\n\nJournal Article"
  },
  {
    "objectID": "portfolio/index.html#pharmacoepidemiology",
    "href": "portfolio/index.html#pharmacoepidemiology",
    "title": "Portfolio",
    "section": "Pharmacoepidemiology",
    "text": "Pharmacoepidemiology\n\nDrug Utilization Research\n\nTramadol Use in the United States, 2005-2021\n\nPoster Presentation\n\n\n\n\n\n\n\n\n\n\nFigure 5\n\n\n\n\n\nJournal Article\nPublished in the American Journal of Preventive Medicine, the most comprehensive analysis of tramadol dispensations estimated trends in rates of new and ongoing use of tramadol by state since August 2014: when tramadol was placed into Schedule IV of the Controlled Drugs and Substances Act. Amounts, prescribers, co-dispensed medications, comorbidities, care settings, and demographics were analyzed among people newly initiating tramadol from 2005-2021 using commercial health insurance claims.\n\n\n\n\n\n\n\n\n\n\nFigure 6\n\n\n\n\n\n\nMultilevel and mixed effects modelling in drug utilization trend analysis: a reproducible tutorial in R and SAS\nThis project was borne from the tramadol study above, detailing methods and code for negative binomial random intercept and random slope trend models in simulated aggregate count data on opioid initiations in fictional regions. Still under development.\n\n\n\nComparative Safety Research\n\nDrug-drug interaction between oxycodone and calcium channel blockers (CCBs) in risk of opioid overdose\n\nPoster Presentation\nThe first presentation of this work was at ICPE on August 28th, 2024 in Berlin, Germany.\n\n\n\n\n\n\n\n\n\n(a) #fig-4\n\n\n\n\n\nFigure 7"
  },
  {
    "objectID": "portfolio/index.html#health-equity",
    "href": "portfolio/index.html#health-equity",
    "title": "Portfolio",
    "section": "Health Equity",
    "text": "Health Equity\n\nWhat will it take to achieve meaningful action on TB among Indigenous Peoples?\n\n\n\n\n\n\nFigure 8\n\n\n\n\n\nChair of the Global Stop TB Initiative (GISI)\nAs (past) Chair of the Global Stop TB Initiative (GISI) of the International Union Against TB and Lung Disease, I expanded and deepened our organization’s bond with Communities, Alliances, and Networks (CAAN).\n\n\n\n\n\n\nFigure 9\n\n\n\n\n\nOne Vision Many Paths: Podcast Interview\nDuring this interview, I was invited to share information about TB for a podcast raising awareness of TB among Indigenous Peoples and advancing Indigenous solutions. I also shared perspectives and from my experience working in Northern Manitoba on TB.\n\n\n\n\n\n\nFigure 10\n\n\n\n\nRECORD-Race and Ethnicity\nRECORD-Race and Ethnicity was first presented at the International Conference on Pharmacoepidemiology, August 28th, 2024 in Berlin, Germany.\n\n\n\n\n\n\nFigure 11"
  },
  {
    "objectID": "portfolio/index.html#indigenous-peoples-health",
    "href": "portfolio/index.html#indigenous-peoples-health",
    "title": "Portfolio",
    "section": "Indigenous Peoples’ Health",
    "text": "Indigenous Peoples’ Health\nWorking for Indigenous Political/Territorial Organizations, MKO and AMC, opened my eyes to massive inequities in health between Indigenous and non-Indigenous Canadians, and the political structures that create and maintain them, formed the basis of my public health worldview and lifelong commitment to health equity."
  },
  {
    "objectID": "portfolio/index.html#injury-epidemiology-research",
    "href": "portfolio/index.html#injury-epidemiology-research",
    "title": "Portfolio",
    "section": "Injury Epidemiology Research",
    "text": "Injury Epidemiology Research\n\nTrends in Homicide Mortality Rates in Canada\n\n\n\n\n\n\nFigure 12"
  },
  {
    "objectID": "projects.html",
    "href": "projects.html",
    "title": "Projects",
    "section": "",
    "text": "The goal of this program of methodological research is to advance theory, concepts, models, and tools for descriptive, predictive, and causal inference about critical illness survivor health outcomes and services.\n\n\n\nBasham CA, Romanowski K, Johnston JC. Life after tuberculosis: planning for health. Lancet Respiratory Medicine. 2019;7(12):1004–1006.\nBasham CA. Post–tuberculosis outcomes science: a sub–discipline for TB survivorship research? International Journal of Tuberculosis and Lung Disease. 2021; 25(6):498-501.\nBasham CA, Smith S, Romanowski K, Johnston JC. Cardiovascular morbidity and mortality among people diagnosed with tuberculosis: a systematic review and meta-analysis. PLoS ONE 15(7):e0235821.\nBasham CA, Cook, VJ, Johnston JC. Towards a ‘fourth 90’: A population–based analysis of post–tuberculosis pulmonary function testing in British Columbia, Canada, 1985–2015. European Respiratory Journal. April 2020:2000384.\nBasham CA, Karim ME, Cook VJ, Patrick DM, Johnston JC. Post–tuberculosis mortality risk among immigrants to British Columbia, Canada, 1985–2015: a time–dependent Cox regression analysis of linked immigration, public health, and vital statistics data. Can J Public Heal. 2021;112(1):132–141.\nBasham CA, Karim ME, Cook, VJ, Patrick DM, Johnston JC. Post–tuberculosis airway disease among people immigrating to British Columbia, Canada, 1985–2015: a population–based cohort study. EClinicalMedicine. 2021;33:100752.\nBasham CA, Karim ME, Cook, VJ, Patrick DM, Johnston JC. Tuberculosis–associated depression risk: a population–based cohort study of people immigrating to British Columbia, Canada, 1985–2015. Annals of Epidemiology. 2021; 63: 7-14.\nBasham CA, Karim ME. An E–value analysis of potential unmeasured or residual confounding in systematic reviews of post–TB mortality, respiratory disease, and cardiovascular disease. Annals of Epidemiology. 2022; 68: 24-31.\nBasham CA, Karim ME, Johnston JC. Multimorbidity prevalence and chronic disease patterns among tuberculosis survivors in a high-income setting. Can J Public Heal. 2023 Apr;114(2):264-276."
  },
  {
    "objectID": "projects.html#survivorship-epidemiology",
    "href": "projects.html#survivorship-epidemiology",
    "title": "Projects",
    "section": "",
    "text": "The goal of this program of methodological research is to advance theory, concepts, models, and tools for descriptive, predictive, and causal inference about critical illness survivor health outcomes and services.\n\n\n\nBasham CA, Romanowski K, Johnston JC. Life after tuberculosis: planning for health. Lancet Respiratory Medicine. 2019;7(12):1004–1006.\nBasham CA. Post–tuberculosis outcomes science: a sub–discipline for TB survivorship research? International Journal of Tuberculosis and Lung Disease. 2021; 25(6):498-501.\nBasham CA, Smith S, Romanowski K, Johnston JC. Cardiovascular morbidity and mortality among people diagnosed with tuberculosis: a systematic review and meta-analysis. PLoS ONE 15(7):e0235821.\nBasham CA, Cook, VJ, Johnston JC. Towards a ‘fourth 90’: A population–based analysis of post–tuberculosis pulmonary function testing in British Columbia, Canada, 1985–2015. European Respiratory Journal. April 2020:2000384.\nBasham CA, Karim ME, Cook VJ, Patrick DM, Johnston JC. Post–tuberculosis mortality risk among immigrants to British Columbia, Canada, 1985–2015: a time–dependent Cox regression analysis of linked immigration, public health, and vital statistics data. Can J Public Heal. 2021;112(1):132–141.\nBasham CA, Karim ME, Cook, VJ, Patrick DM, Johnston JC. Post–tuberculosis airway disease among people immigrating to British Columbia, Canada, 1985–2015: a population–based cohort study. EClinicalMedicine. 2021;33:100752.\nBasham CA, Karim ME, Cook, VJ, Patrick DM, Johnston JC. Tuberculosis–associated depression risk: a population–based cohort study of people immigrating to British Columbia, Canada, 1985–2015. Annals of Epidemiology. 2021; 63: 7-14.\nBasham CA, Karim ME. An E–value analysis of potential unmeasured or residual confounding in systematic reviews of post–TB mortality, respiratory disease, and cardiovascular disease. Annals of Epidemiology. 2022; 68: 24-31.\nBasham CA, Karim ME, Johnston JC. Multimorbidity prevalence and chronic disease patterns among tuberculosis survivors in a high-income setting. Can J Public Heal. 2023 Apr;114(2):264-276."
  },
  {
    "objectID": "projects.html#foundations-for-pharmacoequity",
    "href": "projects.html#foundations-for-pharmacoequity",
    "title": "Projects",
    "section": "Foundations for Pharmacoequity:",
    "text": "Foundations for Pharmacoequity:\nData provenance, lineage, and epidemiological analysis methods for health equity, focusing on race and ethnicity data use in pharmacoepidemiology;"
  },
  {
    "objectID": "projects.html#causing-careers",
    "href": "projects.html#causing-careers",
    "title": "Projects",
    "section": "Causing Careers:",
    "text": "Causing Careers:\nepidemiological approaches to education and career planning, delivery, and evaluation."
  },
  {
    "objectID": "short_cv.html",
    "href": "short_cv.html",
    "title": "C. Andrew Basham",
    "section": "",
    "text": "Education:\n2024 Harvard Medical School - Research Fellow in Medicine - Division of Pharmacoepidemiology and Pharmacoeconomics\n2021 University of British Columbia - PhD in Population and Public Health\n2016 University of Manitoba - MSc Community Health Sciences\n2008 University of Winnipeg - BA Environmental/Urban Studies\nExperience 2008-2010 Health Policy Analyst Health Department Manitoba Keewatinowi Okimakanak 2012 Research Assistant Department of Emergency Medicine University of Manitoba 2012-2013 Statistical Analyst First Nations Regional Longitudinal Health Survey Assembly of Manitoba Chiefs 2013 Program Specialist Aboriginal Health Programs Winnipeg Regional Health Authority 2014-2015 Research Assistant Centre for Aboriginal Health Research University of Manitoba 2015 Research Consultant Health Department Manitoba Keewatinowi Okimakanak 2015-2017 Data Analyst Manitoba Centre for Health Policy University of Manitoba 2017-2021 Graduate Research Assistant Tuberculosis Program British Columbia Centre for Disease Control 2018 Teaching Assistant School of Population and Public Health University of British Columbia 2019 Graduate Research Assistant Department of Pathology and Laboratory Medicine University of British Columbia 2020-2021 Graduate Research Assistant Canadian Disability Participation Project University of British Columbia 2021-2022 Evidence Reviewer McGill International TB Centre McGill University 2022- Statistical Consultant Faculty of Health Sciences Simon Fraser University 2022-2024 Research Fellow Division of Pharmacoepidemiology and Pharmacoeconomics Brigham and Women’s Hospital"
  }
]